Please be advised that we’ve changed pharmacy software. This means the process for submitting online refills will change as well. Your previous logins and our mobile app will no longer work. Please click the Refill Now button to begin the new process. Thank you for your patience during this transition.
Two experimental vaccines show promise in protecting against infection with the "mono" virus, which also causes cancer and has been implicated as a potential trigger of multiple sclerosis, a new paper reports.
Tested only in animals so far, the vaccines block two pathways by which the Epstein-Barr virus (EBV) ta...
Some folks suffering COVID long-haul symptoms might actually be experiencing an attack of fatigue-inducing Epstein-Barr virus (EBV), a new study argues.
Two-thirds of a group of 30 COVID long-haul patients had high levels of Epstein-Barr antibodies, suggesting that EBV lying dormant in their bodies had been reactivated by their coronavirus infection, researchers reported.
As if having the exhausting "kissing disease" -- also known as mononucleosis, or "mono" -- isn't bad enough, about 1 in 10 people with this infection will develop chronic fatigue syndrome in six months, researchers report.
To better predict which people with mono might end up with debilitating chronic fatigue syndrome, investigators at Lurie Children's Hospital of Chicago developed ...